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Abstract 
 
Infection with Toxoplasma gondii is a significant problem in Australian marsupials, and can lead to 
devastating disease and predispose animals to predation. T. gondii infection in kangaroos is also of 
public health significance due to the kangaroo meat trade. A moderate seroprevalence of T. gondii 
was observed in a study of western grey kangaroos located in the Perth metropolitan area in 
Western Australia. Of 219 kangaroos tested, 15.5% (95%CI: 10.7-20.3) were positive for T. gondii 
antibodies using an ELISA developed to detect T. gondii IgG in macropod marsupials. When 
compared with the commercially available MAT (modified agglutination test), the ELISA 
developed was in absolute agreement and yielded a κ coefficient of 1.00. Of 18 kangaroos tested 
for the presence of T. gondii DNA by PCR, the 9 ELISA positive kangaroos tested PCR positive 
and the 9 ELISA negative kangaroos tested PCR negative indicating the ELISA protocol was both 
highly specific and sensitive and correlated 100% with the more labour intensive PCR assay. 
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1. Introduction 
 
Australian marsupials are among the most susceptible hosts for Toxoplasma gondii and the 
parasite is known to cause both chronic and acute infection [1, 2]. Infection in marsupials is not 
always fatal and can result in long-term latent infection which may be reactivated during times of 
stress [3]. T. gondii infection may make a marsupial more prone to predation by affecting its 
movement, coordination and sight [4, 5].  Not only is infection with T. gondii attributed to causing 
declines in marsupial populations in the wild [6, 7], toxoplasmosis is associated with widespread 
pathology and death in several collections of captive marsupials [8-16]. Captivity is a stressor and ACCEPTED MANUSCRIPT
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therefore thought to increase the chance of reactivated T. gondii infection [1, 3, 17]. Clinical signs 
of toxoplasmosis in Australian marsupials vary and include diarrhoea, respiratory distress, weight 
loss, blindness, neurological deficits and sudden death [18]. Common histopathological findings 
include myocardial, skeletal and smooth muscle necrosis, with T. gondii cysts and tachyzoites in 
areas of necrosis and interstitial pneumonia of the lungs [8]. Due to the dynamics of T. gondii 
infection in marsupials, knowledge of the T. gondii serological status of marsupials is of immense 
benefit to their management in captivity and in the wild. Although a number of cases of 
toxoplasmosis are described in captive marsupials, there is little recent data on the prevalence and 
distribution of T. gondii infection in wild marsupials. T. gondii seroprevalence in free ranging 
marsupials was 3.3% in Bennett’s wallabies and 17.7% in Tasmanian pademelons using an ELISA 
[19], and 15% in bridled nailtail wallabies using a latex agglutination test [20]. In addition, T. 
gondii seroprevalence levels of 6.7% in eastern barred bandicoots [6] and 6.3% in the common 
brushtail possum [7] were observed using the MAT. Not only is the prevalence of T. gondii in wild 
marsupials of importance in terms of conservation, the presence of infection in wild kangaroos in 
particular is of public health significance due to the kangaroo meat trade. 
Infection with T. gondii can be diagnosed in a number of ways. Diagnosis using histology 
and bioassay detect T. gondii organisms themselves but require tissue from dead animals. 
Furthermore, during chronic infection, T. gondii is spread sparsely within tissues and is often 
difficult to detect with histology [21]. Bioassays, although highly sensitive and specific at detecting 
T. gondii infection, are expensive and labour intensive [22]. PCR detection of T. gondii DNA also 
necessitates invasive sampling techniques or necropsy. In contrast, serology identifies serum 
antibodies, which are easy to detect during routine blood screening. One limitation of serology is 
that cross-reactive antibodies in animals infected with related coccidian parasites may give false 
positive results.   ACCEPTED MANUSCRIPT
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During studies which involved the screening of western grey kangaroos for T. gondii 
antibodies, the modified agglutination test was used. The MAT (Toxo-Screen DA, bioMerieux, 
France) was chosen to screen initial sera samples because it is the most commonly used test for 
serodiagnosis of T. gondii infection in Australian marsupials [10, 18, 23-26] and is the only test 
routinely used to screen marsupials for T. gondii infection in zoos throughout Australia. Published 
studies have shown a good correlation between MAT positivity in marsupials and infection with T. 
gondii [6, 27]. The popularity of the MAT in marsupials stems from the test not requiring a 
species-specific secondary reagent to detect the T. gondii antibodies circulating in infected animals, 
so enabling it to be used on a range of marsupial species. In addition, the MAT has been used 
extensively for the diagnosis of toxoplasmosis in a range of other species [28] and is used as a 
sensitive and specific test to detect T. gondii IgG antibodies in humans [29], mice [30], pigs [31], 
sheep [32] and felids [33, 34]. For routine screening of western grey kangaroos for T. gondii 
antibodies using the MAT, however, we found the test to be cost prohibitive. We therefore 
developed an ELISA to detect T. gondii IgG in macropod marsupials. This ELISA was found to be 
in absolute agreement with the MAT. The ELISA was then used to determine the seroprevalence of 
T, gondii in wild macropods within the Perth metropolitan area. The ELISA test was subsequently 
validated using a highly-specific PCR approach to confirm the presence of infection with T. gondii 
DNA in a cohort of seropositive animals. 
 
2. Materials and Methods 
 
2.1. Modified agglutination test 
 
Sera from 52 western grey kangaroos (Macropus fuliginosus) were tested using the 
commercially available MAT. Sera were tested at two different sera dilutions; 1:40 and 1:4000, ACCEPTED MANUSCRIPT
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according to the manufacturer’s instructions. The positive and negative control sera included in the 
kit were used in each round of samples tested, in addition to an antigen control comprised of PBS. 
A serum sample was determined to be T. gondii positive when an agglutination reaction was 
observed at a serum dilution of at least 1:40, based on the manufacturer’s directions.  
 
2.2 ELISA development 
 
MAT tested sera were used to optimise the in-house ELISA. Antigen for the ELISA was 
prepared from the Type I RH strain of T. gondii tachyzoites grown in Vero cell culture adapted 
from [35]. After infected cell cultures were harvested, tachyzoites were purified from the Vero cells 
by shearing through a 30G needle then filtration with a 5μm syringe filter. Purified tachyzoites 
were washed twice in PBS pH 7.2. The suspension of tachyzoites in PBS was then sonicated for 3 
periods of 1 minute at a power level of 5 (Sonicator
R Ultrasonic Processor, Misonix incorporated, 
Farmingdale, USA). Nuclei and membranes were spun out at 10,000g for 30 minutes to produce a 
soluble tachyzoite antigen preparation. A Bradford protein assay (Quick Start 
TM Bradford Dye 
Reagent, Biorad Laboratories, Gladesville, Australia) was undertaken and the antigen concentration 
adjusted with a volume of PBS to produce a 1000μg/ml protein preparation. 
The optimum concentrations of antigen, serum and reagents for the ELISA were 
determined using a checker board system with antigen diluted in one direction and a series of 
different sera and reagent concentrations diluted in opposite directions. Four dilutions of antigen, 1 
μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, were tested, with two MAT positive and two MAT negative 
sera samples diluted at 1:100, 1:200 and 1:400. The dilution of serum and antigen with the highest 
difference between positive and negative were then selected for use in assays to determine the 
optimum concentration of secondary and tertiary reagent.  Three dilutions of secondary reagent, 
1:500, 1:1000 and 1:2000, were tested against three dilutions of tertiary reagent, which were ACCEPTED MANUSCRIPT
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1:1000, 1:2000 and 1:4000 and a serum dilution of 1:400 was used with an antigen concentration of 
1 μg/ml. Two MAT positive and two MAT negative western grey kangaroo sera were used in the 
initial optimisation assays. After the optimal antigen and reagent concentrations were identified, 1 
positive and 5 negative sera samples were tested at 8 sequential dilutions from 1:400 to 1:51200, 
using a secondary and tertiary reagent concentration of 1:1000 each. The serum dilution with the 
highest difference between positive and negative was chosen as the serum dilution for use in the 
ELISA; this was a serum dilution of 1:800. After the concentration of antigen, reagents and sera 
were optimised, a total of 54 MAT tested macropod serum samples were used to validate the 
ELISA and establish a positive cut-off point for optical density. The cut-off point was determined 
by calculating the mean optical density (OD) plus 3 standard deviations (SD) [36, 37] of MAT 
negative sera, this was 0.636. A sera sample with an OD reading equal to the mean plus 3 SDs of 
MAT negative sera was used as a reference positive control. For control of plate to plate variation, 
2 negative and 2 positive control sera, including the reference positive control, were included on 
every plate. A serum sample was considered to be positive when its OD value was greater than that 
of the reference positive control, as described in [38]. 
The final protocol for the ELISA commenced with T. gondii antigen diluted in 50mM 
carbonate buffer, pH 9.6, to a concentration of 1 μg/ml. One hundred microliters of diluted antigen 
was then added to every well of a 96 well ELISA plate (Microlon 600, Greiner Bio-one, 
Frickenhausen, Germany). The 96 well plate was incubated for 1 hour at 37
oC. A washing cycle 
followed which consisted of rinsing in PBS with 0.05% Tween 20 for three periods of 3 minutes. 
The ELISA plate was blocked for 1 hour using 150 μl of 5% skim milk powder in PBS 0.05% 
Tween 20 and washed. Duplicates of test sera samples diluted in 5% skim milk in PBS were added 
at a volume of 100 μl and concentration of 1:800. Two MAT seropositive and two MAT 
seronegative sera samples were included in every 96 well plate tested. Sera was incubated for 90 
minutes at 37
oC and the plate washed prior to the addition of 100μl of commercially available ACCEPTED MANUSCRIPT
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unconjugated Rabbit anti-kangaroo IgG (Kangaroo IgG (h&I) Antiserum, Bethyl Laboratories Inc, 
Montgomery, USA) at a concentration of 1:1000. The ELISA plate was then incubated for a further 
60 minutes and washed after which 100 μl of Horseradish Peroxidase (HRP)-conjugated anti-
Rabbit antibody (Donkey Anti-Rabbit: HRP, Affinity Bioreagents
TM, Golden, USA) was added at a 
concentration of 1:1000. After the final incubation period of 60 minutes, the plate was washed and 
200  μl OPD (o-phenylenediamine Dihydrochloride) Substrate Solution (Sigma Fast
TM OPD, 
SIGMA, Saint Louis, USA) added. The OPD was left in the dark at room temperature for 15 
minutes before the reaction was stopped with 50 μl of 2M H2SO4. The optical density was then 
read at 450nm using a spectrophotometer. Serum samples tested using the MAT, and used to 
optimize the ELISA, were retested using the final ELISA protocol (Table 1). 
 
2.3 Seroprevalence study 
 
Two hundred and twenty western grey kangaroo sera were obtained from 7 different 
locations on the outskirts of the Perth metropolitan area over an 18 month period.  Kangaroos were 
culled during Department of Environment and Conservation (DEC) population control programmes 
in areas such as parks, reserves, golf courses and farms due to overpopulation. During culling 
programmes an ID was allocated to each animal and the sex of the kangaroo noted. Blood was 
collected by needle aspiration of the heart within 4 hours of death of the kangaroo. Sera was 
separated by centrifugation and stored at -20
oC. Fifty four of these sera samples were tested using 
both the MAT and ELISA, while the remaining were tested using the ELISA only.  
Brain and tongue tissue from 62 of the 220 adult kangaroos were collected during the 
kangaroo culling programmes in Perth. The head of each kangaroo was removed in the field and 
transported to our laboratory for processing. Samples of brain and tongue were then removed from 
the head of adult kangaroos, placed in sterile containers and frozen at -20°C. The pouch young of ACCEPTED MANUSCRIPT
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all 62 kangaroos were also killed in line with DEC population control measures, via blunt trauma to 
the head. Samples of brain and heart were removed from the pouch young once transported to our 
laboratory. Tissue samples were placed in sterile containers and frozen at -20°C. 
 
2.4 DNA extraction and PCR 
 
The B1 gene [39] and ITS1 locus [40] were amplified using nested PCR to test for T. 
gondii DNA in 9 ELISA positive and 9 ELISA negative western grey kangaroos in which both sera 
samples and tissues were obtained. B1 gene primers used for nested PCR were: Pml/S1, 5’-
TGTTCTGTCCTATCGCAACG; Pml/S2, 5’-TCTTCCCAGACGTGGATTTC; Pml/AS1, 5’-
ACGGATGCAGTTCCTTTCTG; Pml/AS2, 5’-CTCGACAATACGCTGCTTGA. ITS1 locus 
primers used for hemi-nested PCR were: 22/FWD, 5’-GGGAAGTTTTGTGAACCT; ITS-5, 5’-
GGAAGTAAAAGTCGTAACAAGG; ITS-2, 5’-GCTGCGTTCTTCATCGATGC. Tissue samples 
tested included brain, tongue and heart samples. DNA was extracted using a QIAamp DNA 
MiniKit (QIAGEN, Hilden, Germany). For PCR, 1μl of template DNA was added to a total 
reaction volume of 50μl, which consisted of 5μl of 10x PCR buffer (SIGMA PCR Buffer 10x 
containing 15mM MgCl2, SIGMA, Saint Louis, USA), 5μl of 2mM dNTPs, 0.4μl of 50pmol 
forward primer, 0.4μl of 50 pmol reverse primer and 1.25 U of Taq Polymerase (SIGMA taq DNA 
polymerase A, SIGMA, Saint Louis, USA). DNA from the RH strain of T. gondii was used as a 
positive PCR control and PCR negative controls consisted of distilled water. Amplification 
consisted of denaturing at 94°C for 5 minutes followed by 30 cycles of 94°C for 40 seconds, 60°C 
for 40 seconds and 72°C for 90 seconds, after which there was an extension period of 10 minutes at 
72°C. PCR products were visualized using 0.8% agarose gels stained with ethidium bromide. PCR 
products from the ITS1 PCR were sequenced to identify a T. gondii specific DNA sequence. 
 ACCEPTED MANUSCRIPT
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2.5 Statistics 
 
Agreement between the MAT and ELISA was estimated by κ coefficient [41]. The Pearson 
p value of the Chi squared test [42] and odds ratios [43] were utilized to compare the 
seroprevalence results of male and female western grey kangaroos. A p value of less than 0.05 was 
considered statistically significant. Odds ratios were calculated with 95% confidence intervals. 
 
3. Results 
 
The in-house ELISA was in absolute agreement with the MAT as illustrated in Table 1 and 
yielded a κ coefficient of 1. All 47 MAT negative sera samples were ELISA negative and all 7 
MAT positive sera samples were ELISA positive (Table 1).  
The optimised ELISA protocol was used consistently in kangaroo samples tested in the T. 
gondii seroprevalence study (Table 2). Of the 219 western grey kangaroos sampled within the Perth 
metropolitan area, 15.5% (95%CI: 10.7-20.3), were seropositive for T. gondii using the in-house 
ELISA. Male kangaroos had an overall seroprevalence of 10.9% compared to 21.5% for females. 
This difference was statistically significant (p = 0.038; OR = 0.45, CI: 0.21, 0.97). 
The results of the PCR were consistent with the ELISA results (Table 3). T. gondii specific 
DNA was detected in all nine animals that had sera which was ELISA positive. In addition, all 
tissue samples from ELISA negative kangaroos were PCR negative for T. gondii DNA using 
primers for both the B1 gene  [39] and ITS1 locus [40]. Clean PCR amplification products were 
observed for both the B1 gene (data not shown) and ITS1 locus (Figure 1). All ITS1 positive PCR 
samples were sequenced, and BlastN analysis of the DNA sequences revealed that the amplicons 
were specific for T. gondii (data not shown). 
 ACCEPTED MANUSCRIPT
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4. Discussion 
 
The seroprevalence of T. gondii in western grey kangaroos in this study was found to be 
15.5% (95%CI: 10.7-20.3). This is similar to the 17.7% seroprevalence levels found in wild 
Tasmanian pademelons [19], and the 15.5% seroprevalence in free ranging bridled nailtail 
wallabies [20]. The prevalence of T. gondii antibodies in Bennett’s wallabies was lower at 3.3% 
and was also lower in smaller sized, non macropod marsupial species such as common brushtail 
possum and eastern barred bandicoots which were 6.3% [7] and 6.7% [6] respectively. The 
moderate seroprevalence of T. gondii in wild western grey kangaroos confirms kangaroos can 
survive with T. gondii infection in the wild. Thirty four kangaroos in the Perth Metropolitan area 
had evidence of exposure to T. gondii. The source of T. gondii for these kangaroos is unknown at 
this time, as there is no information regarding the presence of infected cats in the areas surveyed. 
Felids are the only definitive host of T. gondii and there are no native Australian felids, leaving 
domestic and feral cats as the only source of T. gondii oocysts. Another possible source of T. 
gondii infection is congenital transmission. Evidence for congenital transmission in marsupials to 
date is anecdotal [10, 11] however it is well established in a number of species including sheep, 
mice, rats, cats and humans [44-46]. Kangaroos are herbivorous, therefore T. gondii infected 
animal tissue is an unlikely source of infection in the western grey kangaroos tested. 
In this study of western grey kangaroos, the prevalence in males was significantly less than 
in female kangaroos (p<0.05). A few other studies published have also identified a significantly 
higher T. gondii seroprevalence in female sheep and goats compared to their male counterparts [47, 
48]. It is possible that differences in behaviour between male and female western grey kangaroos 
accounts for their different levels of exposure to T. gondii. For example it is thought that female 
kangaroos are able to crop short grass better than males [49]. Males may then be forced onto other ACCEPTED MANUSCRIPT
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food and may be seen camped separately from females [50]. Females which graze close to the 
ground may be thus more likely to be exposed to T. gondii oocysts in soil. 
Absolute agreement between T. gondii ELISA results and the PCR results was found in the 
18 kangaroos tested using both ELISA and PCR. Other studies have found PCR to be far less 
sensitive than serology at detecting T. gondii infection in pigs [22, 51] and cattle [52]. The PCR 
used in this study was found to have a high sensitivity for detecting T. gondii DNA in ELISA 
positive western grey kangaroos, which could indicate that marsupials possess higher tissue 
burdens of parasites than for instance, pigs and cattle. All ITS1 PCR products were sequenced and 
the results confirmed that the amplicons were that of T. gondii in the tissue samples of seropositive 
animals.  T. gondii DNA was not detected in the tissues of 9 seronegative kangaroos, which 
consisted of 3 adults and 6 pouch young. Although T. gondii has been detected in seronegative 
animals previously [53], this is reported infrequently. PCR results from DNA extracted from 
seropositive and seronegative kangaroos correlated exactly with the serological results suggesting 
the ELISA developed is sensitive and specific.  
Fifty two MAT-tested serum samples were used to validate and optimize the ELISA 
developed in this study. This ELISA was found to have a comparable sensitivity and specificity to 
the MAT, based on its Kappa value of 1. The principle advantage of the ELISA is that it can be 
used to screen large amounts of sera samples more cost effectively than the commercially available 
MAT. ELISA results can also be easily interpreted based on the cut off point for optical density, as 
compared to an IFAT where slides need to be examined by experienced readers. Due to the 
relatively high serum dilution used in this ELISA protocol, only a small amount of marsupial 
serum is required to detect T. gondii antibodies. This is of particular benefit in wildlife research as 
only small volumes of sera are usually obtainable in live trapped animals and these are often used 
to test for multiple conditions. This ELISA could theoretically be easily modified to suit non-
macropodine marsupials by changing the secondary reagent. ACCEPTED MANUSCRIPT
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It is unknown if kangaroos are infected with coccidia other than T. gondii and produce 
cross reactive antibodies. Cross reactive antibodies to T. gondii reduce the specificity of serological 
tests. The specificity of the MAT in marsupials is unknown, however as the MAT is the most 
commonly used and widely accepted test to screen for anti-T. gondii IgG in marsupials, the MAT 
was used in this study as a reference test to optimise and validate the in-house ELISA protocol. 
PCR of tissues from ELISA positive and negative kangaroos was used to further validate the 
ELISA results. The number and range of coccidia that infect Australian marsupials is unknown, 
therefore the level of cross reactivity that exists in wild kangaroos infected with other coccidia is 
unknown. Furthermore, the absolute agreement between the MAT and ELISA suggests the ELISA 
developed has a similar specificity to the MAT and is suitable for use in seroprevalence studies and 
serodiagnosis. The high agreement between the ELISA results and PCR results also suggest the 
ELISA developed is sensitive and specific.   
In this study we found a moderate seroprevalence of T. gondii in wild western grey 
kangaroos, using an in house ELISA. Infection with T. gondii in marsupials has the potential to 
progress to fulminant disease, alters the way marsupials should be managed in captivity and is a 
public health issue as kangaroo meat is now commonly consumed by humans and domestic felids 
[54]. Wild western grey kangaroos are harvested for meat in Australia [55]. Kangaroo meat is 
commonly enjoyed rare and kangaroo pet meat is regularly served raw. T. gondii bradyzoites 
remain infective when meat is undercooked, making the ingestion of rare or raw kangaroo meat a 
risk factor in T. gondii transmission [54]. T. gondii infected kangaroos are not only a source of 
infection for humans, but also for domestic cats, which may subsequently shed oocysts and 
perpetuate the life cycle.  
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Figure 1 
ITS1 PCR agarose gel. Lane 1, 100bp DNA ladder. Lane 2, pouch young 1, brain. Lane 3, pouch 
young 1, heart. Lane 4, pouch young 2, brain. Lane 5, pouch young 2, heart. Lane 6, pouch young 
3, brain. Lane 7, pouch young 3, heart. Lane 8, adult 8, brain. Lane 9, adult 8, tongue. Lane 10, 
adult 9, brain. Lane 11, adult 9, tongue. Lane 12, pouch young 4, brain. Lane 13, pouch young 4, 
heart. Lane 14, pouch young 5, brain. Lane 15, pouch young 5, heart, Lane 16, pouch young 6 
brain, Lane 17, pouch young 6 heart. Lane 18, adult 1, brain.  Lane 19, T. gondii positive control. 
Lane 20, T. gondii negative control. ACCEPTED MANUSCRIPT
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Table 1 
Level of agreement between a commercially available MAT and an ELISA in western grey 
kangaroos 
 ELISA 
MAT +  - 
+ 7 0 
- 0 47 
 
Table 2 
Prevalence of T. gondii antibodies in western grey kangaroos as determined by ELISA 
Sex  Number positive  Number tested  Prevalence
Male 11  101 10.9%
Female 23  107 21.5%
Unknown 0  11 0.0%
TOTAL 34  219 15.5%
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Table 3 
PCR results of ELISA positive and negative western grey kangaroos 
   PCR results 
Animal ELISA  result  Brain  Tongue 
Adult 1  Positive  B1, ITS1  Negative 
Adult 2  Positive  B1, ITS1  ITS1 
Adult 3  Positive  B1, ITS1  ITS1 
Adult 4  Positive  nd  B1, ITS1 
Adult 5  Positive  B1, ITS1  Negative 
Adult 6  Positive  Negative  B1, ITS1 
Adult 7  Positive  Negative  ITS1 
Adult 8  Positive  ITS1  Negative 
Adult 9  Positive  ITS1  Negative 
Adult 10  Negative  Negative  Negative 
Adult 11  Negative  Negative  Negative 
Adult 12  Negative  Negative  Negative 
   Brain  Heart 
Pouch young 1  Negative  Negative  Negative 
Pouch young 2  Negative  Negative  Negative 
Pouch young 3  Negative  Negative  Negative 
Pouch young 4  Negative  Negative  Negative 
Pouch young 5  Negative  Negative  Negative 
Pouch young 6  Negative  Negative  Negative 
nd- not tested 
 